Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death

• Published in: Oncogene Vol. 35; no. 40; pp. 5282 - 5294
• Main Authors: Bhattacharya, S, Chalk, A M, Ng, A J M, Martin, T J, Zannettino, A C, Purton, L E, Lu, J, Baker, E K, Walkley, C R
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 06.10.2016; Nature Publishing Group
• Subjects: 13/2; 13/31; 13/89; 38/39; 38/90; 631/67/1798; 64/60; 82/80; Analysis; Animal models; Animals; Apoptosis; Apoptosis - genetics; Biochemistry; Bone cancer; Cell Biology; Cell death; Cell Differentiation - genetics; Cell fate; Cell Line, Tumor; Cell proliferation; Cell Proliferation - genetics; Computer applications; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Genetic engineering; Genetically modified organisms; Human Genetics; Humans; Internal Medicine; Medicine; Medicine & Public Health; Metastases; Mice; MicroRNA; MicroRNAs; MicroRNAs - biosynthesis; MicroRNAs - genetics; miRNA; Necroptosis; Oncology; original-article; Osteoblasts; Osteosarcoma; Osteosarcoma - genetics; Osteosarcoma - pathology; Protein-serine/threonine kinase; Receptor-Interacting Protein Serine-Threonine Kinases - genetics; Sarcoma; siRNA; Tumor cells; Wildlife conservation; Young adults
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/onc.2016.68

Osteosarcoma (OS) is the most common cancer of bone and the 5th leading cause of cancer-related death in young adults. Currently, 5-year survival rates have plateaued at ~70% for patients with localized disease. Those with disseminated disease have an ~20% 5-year survival. An improved understanding of the molecular genetics of OS may yield new approaches to improve outcomes for OS patients. To this end, we applied murine models that replicate human OS to identify and understand dysregulated microRNAs (miRNAs) in OS. miRNA expression patterns were profiled in murine primary osteoblasts, osteoblast cultures and primary OS cell cultures (from primary and paired metastatic locations) isolated from two genetically engineered murine models of OS. The differentially expressed miRNA were further assessed by a cross-species comparison with human osteoblasts and OS cultures. We identified miR-155-5p and miR-148a-3p as deregulated in OS. miR-155-5p suppression or miR-148a-3p overexpression potently reduced proliferation and induced apoptosis in OS cells, yet strikingly, did not impact normal osteoblasts. To define how these miRNAs regulated OS cell fate, we used an integrated computational approach to identify putative candidate targets and then correlated these with the cell biological impact. Although we could not resolve the mechanism through which miR-148a-3p impacts OS, we identified that miR-155-5p overexpression suppressed its target Ripk1 (receptor (TNFRSF)-interacting serine–threonine kinase 1) expression, and miR-155-5p inhibition elevated Ripk1 levels. Ripk1 is directly involved in apoptosis/necroptosis. In OS cells, small interfering RNA against Ripk1 prevented cell death induced by the sequestration of miR-155-5p. Collectively, we show that miR-148a-3p and miR-155-5p are species-conserved deregulated miRNA in OS. Modulation of these miRNAs was specifically toxic to tumor cells but not normal osteoblasts, raising the possibility that these may be tractable targets for miRNA-based therapies for OS.